Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

The SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis.

Blackmore JK, Karmakar S, Gu G, Chaubal V, Wang L, Li W, Smith CL.

Endocrinology. 2014 Sep;155(9):3251-61. doi: 10.1210/en.2014-1002. Epub 2014 Jun 27.

2.
3.

Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.

Karmakar S, Gao T, Pace MC, Oesterreich S, Smith CL.

Mol Endocrinol. 2010 Jun;24(6):1187-202. doi: 10.1210/me.2009-0480. Epub 2010 Apr 14.

5.
6.

Inhibition of MAP kinase promotes the recruitment of corepressor SMRT by tamoxifen-bound estrogen receptor alpha and potentiates tamoxifen action in MCF-7 cells.

Hong W, Chen L, Li J, Yao Z.

Biochem Biophys Res Commun. 2010 May 28;396(2):299-303. doi: 10.1016/j.bbrc.2010.04.085. Epub 2010 Apr 18.

PMID:
20406620
7.

Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.

Vanderlaag KE, Hudak S, Bald L, Fayadat-Dilman L, Sathe M, Grein J, Janatpour MJ.

Breast Cancer Res. 2010;12(3):R32. doi: 10.1186/bcr2586. Epub 2010 Jun 4.

8.

Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence.

Smith CL, Migliaccio I, Chaubal V, Wu MF, Pace MC, Hartmaier R, Jiang S, Edwards DP, Gutiérrez MC, Hilsenbeck SG, Oesterreich S.

Breast Cancer Res Treat. 2012 Nov;136(1):253-65. doi: 10.1007/s10549-012-2262-7. Epub 2012 Sep 27.

9.

G protein pathway suppressor 2 (GPS2) is a transcriptional corepressor important for estrogen receptor alpha-mediated transcriptional regulation.

Cheng X, Kao HY.

J Biol Chem. 2009 Dec 25;284(52):36395-404. doi: 10.1074/jbc.M109.062109. Epub 2009 Oct 26.

10.

[Expression of ER alpha and SMRT in apoptosis of breast cancer cells induced by tamoxifen].

Zhao XH, Wang ZY, Li LL.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2008 May;37(3):276-82. Chinese.

PMID:
18546531
11.
12.

Furanodienone inhibits cell proliferation and survival by suppressing ERα signaling in human breast cancer MCF-7 cells.

Li YW, Zhu GY, Shen XL, Chu JH, Yu ZL, Fong WF.

J Cell Biochem. 2011 Jan;112(1):217-24. doi: 10.1002/jcb.22922.

PMID:
21069738
13.

Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.

Tolhurst RS, Thomas RS, Kyle FJ, Patel H, Periyasamy M, Photiou A, Thiruchelvam PT, Lai CF, Al-Sabbagh M, Fisher RA, Barry S, Crnogorac-Jurcevic T, Martin LA, Dowsett M, Charles Coombes R, Kamalati T, Ali S, Buluwela L.

Breast Cancer Res Treat. 2011 Jul;128(2):357-68. doi: 10.1007/s10549-010-1122-6. Epub 2010 Aug 22.

PMID:
20730598
14.

A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.

Zhan Y, Zhang Y, Liu C, Zhang J, Smith WW, Wang N, Chen Y, Zheng L, He L.

Cancer Prev Res (Phila). 2012 Jun;5(6):864-73. doi: 10.1158/1940-6207.CAPR-11-0575. Epub 2012 Apr 11.

15.

Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.

Karmakar S, Foster EA, Smith CL.

Endocrinology. 2009 Apr;150(4):1588-96. doi: 10.1210/en.2008-1001. Epub 2008 Dec 18.

16.

Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.

Karam M, Bièche I, Legay C, Vacher S, Auclair C, Ricort JM.

J Cell Mol Med. 2014 Dec;18(12):2536-52. doi: 10.1111/jcmm.12322. Epub 2014 Oct 7.

18.

The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.

Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC.

Cancer Res. 2010 Feb 1;70(3):1184-94. doi: 10.1158/0008-5472.CAN-09-3068. Epub 2010 Jan 19.

19.
20.

RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.

Thaler S, Schmidt M, Schad A, Sleeman JP.

Oncogene. 2012 Nov 22;31(47):4912-22. doi: 10.1038/onc.2011.658. Epub 2012 Jan 23.

PMID:
22266866

Supplemental Content

Support Center